Enterovirus 71 Nucleic Acid Detection Kit Growth Trends & Opportunity Analysis 2033

Enterovirus 71 Nucleic Acid Detection Kit by Application (Hospital, Clinic, Other), by Types (RNA Thermostatic Amplification Method, PCR-Fluorescent Probe Method), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 161

Forecast Period: 2026 - 2033

Market Size: $125 million

CAGR: 14.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 161

Forecast Period: 2026 - 2033

Market Size: $125 million

CAGR: 14.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Enterovirus 71 Nucleic Acid Detection Kit Market Size | CAGR 14.2 Forecast 2033

Enterovirus 71 Nucleic Acid Detection Kit Growth Trends & Opportunity Analysis 2033

🏭 Healthcare🌍 Global

Pages: 161

Forecast Period: 2026 - 2033

Market Size: $125 million

CAGR: 14.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 161

Forecast Period: 2026 - 2033

Market Size: $125 million

CAGR: 14.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Enterovirus 71 Nucleic Acid Detection Kit Market Overview

The Enterovirus 71 (EV71) Nucleic Acid Detection Kit market focuses on molecular diagnostic tools designed to identify EV71, a pathogen linked to hand, foot, and mouth disease (HFMD) and severe neurological complications. As HFMD outbreaks persist globally, rapid and accurate detection remains critical for public health interventions. The EV71 Nucleic Acid Detection Kit market size is projected to expand significantly, driven by advancements in molecular diagnostics and rising demand for early diagnosis. This market analysis evaluates growth outlook, regulatory shifts, and regional dynamics to provide actionable insights for stakeholders.

Loading chart…

The EV71 Nucleic Acid Detection Kit market forecast indicates a compound annual growth rate (CAGR) of 8.5% from 2026 to 2033, with the Asia-Pacific region dominating due to recurring HFMD outbreaks and government-funded diagnostic programs. Industry expansion is propelled by technological innovations in PCR and isothermal amplification, alongside stringent regulatory frameworks mandating rapid diagnostic solutions. Conversely, Latin America is emerging as the fastest-growing region, fueled by improved healthcare access and cross-border collaborations. Strategic partnerships between diagnostics firms and public health agencies will further shape market dynamics, while cost constraints and reimbursement challenges may temper growth in low-income regions.

Report Overview

Report Attribute	Details
Market size value in 2025	125.00 million
Revenue forecast in 2033	361.61 million
Growth rate	CAGR of 14.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Bio SB; BioPerfectus; Bioneer; Macro & Micro-Test; Guangdong Hecin Scientific; Sansure Biotech; Jiangsu Mole Bioscience; Shanghai Rendu BIOTECHNOLOGY; Guangdong Huayin Medicine Science; Daan Gene; Zhijiang Biology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising incidence of Enterovirus 71 (EV71) infections, particularly in Asia-Pacific regions, is fueling demand for rapid and accurate diagnostics. Outbreaks linked to hand, foot, and mouth disease (HFMD) have prompted Enterovirus 71 Nucleic Acid Detection Kit market growth as healthcare systems prioritize early diagnosis to mitigate transmission.

Government funding for public health infrastructure and regulatory push for molecular diagnostic adoption are amplifying market expansion. Strategic investments in PCR and isothermal amplification technologies are improving Enterovirus 71 Nucleic Acid Detection Kit market size by enabling scalable testing capacity.

Restraints2 items

High cost of nucleic acid amplification tests (NAATs) compared to rapid antigen tests limits adoption in low-income regions, where budget constraints prioritize cost-effective alternatives despite lower sensitivity.

Regulatory fragmentation across geographies delays product approvals, creating compliance bottlenecks for manufacturers seeking to expand into emerging markets.

Opportunities2 items

Advancements in CRISPR-based diagnostic platforms offer faster results and higher specificity, creating differentiation opportunities for players targeting Enterovirus 71 Nucleic Acid Detection Kit market growth in high-accuracy segments.

Untapped demand in Latin America and Africa presents a strategic growth corridor, driven by improving healthcare access and partnerships with local diagnostic labs.

Challenges2 items

Supply chain disruptions from geopolitical tensions and raw material shortages threaten production timelines and inflate costs for nucleic acid detection kit manufacturers.

Competition from point-of-care (POCT) alternatives erodes market share, as rapid antigen tests gain traction in resource-limited settings despite trade-offs in precision.

Market Segmentation

Loading chart…

The Enterovirus 71 Nucleic Acid Detection Kit segmentation by Application categorizes demand into clinical diagnostics, outbreak surveillance, and pharmaceutical R&D. Clinical diagnostics dominate, driven by hospital and lab testing for hand-foot-and-mouth disease (HFMD) in pediatric populations. Outbreak surveillance contributes significantly in regions with high EV71 prevalence, such as Asia-Pacific, where public health agencies prioritize rapid detection. Pharmaceutical R&D accounts for a smaller share, focused on validating new diagnostic platforms and antiviral therapies. This market taxonomy highlights clinical diagnostics as the largest segment, representing ~65% of total applications, due to its critical role in early intervention and patient management.

Enterovirus 71 Nucleic Acid Detection Kit segmentation by Types includes real-time PCR-based kits, isothermal amplification kits, and CRISPR-based assays. Real-time PCR remains the dominant technology due to its high specificity and widespread adoption in clinical labs. Isothermal methods, such as LAMP and HDA, are growing rapidly in low-resource settings for their portability and cost-effectiveness. CRISPR-based kits, though nascent, offer superior sensitivity and are gaining traction in advanced diagnostic markets. Real-time PCR kits constitute ~70% of the market by value, reflecting their entrenched role in regulatory compliance and diagnostic accuracy. The shift toward isothermal and CRISPR technologies underscores evolving needs for rapid, decentralized testing solutions.

Enterovirus 71 Nucleic Acid Detection Kit Segmentation Breakdown7 items

Application

Hospital

Clinic

Other

Types

RNA Thermostatic Amplification Method

PCR-Fluorescent Probe Method

Regional Insights

Loading chart…

The Asia Pacific region dominates the Enterovirus 71 Nucleic Acid Detection Kit market, accounting for 45% of the global share, driven by high prevalence of outbreaks, robust healthcare investments, and growing diagnostic infrastructure. Rapid urbanization and a large pediatric population further fuel demand. North America follows at 25%, with a mature ecosystem, aggressive R&D funding, and stringent regulatory frameworks ensuring rapid adoption of advanced detection kits. The regional forecast highlights Asia Pacific as the fastest-growing market, supported by government initiatives to improve pediatric healthcare and rising awareness of EV71-related diseases.

Europe (15%) maintains steady growth through centralized healthcare policies, cross-border collaboration in outbreak monitoring, and high adoption of molecular diagnostics. In Latin America (10%), market expansion is spurred by improving healthcare access, increasing EV71 surveillance programs, and partnerships with global diagnostics firms. The Middle East & Africa (5%), while nascent, show potential due to demographic shifts and incremental infrastructure upgrades, though adoption remains constrained by resource limitations.

Key Drivers by Region5 items

Asia Pacific: High demographic density, government funding for pediatric health, and post-outbreak infrastructure development.

North America: Advanced healthcare ecosystems, regulatory prioritization of rapid diagnostics, and private-sector innovation.

Europe: EU-level health directives, robust public health networks, and high diagnostic accuracy standards.

Latin America: Rising awareness, public-private partnerships, and regional outbreak response programs.

Middle East & Africa: Gradual infrastructure modernization, demographic growth, and international aid-driven healthcare projects.

Competitive Landscape

The Enterovirus 71 Nucleic Acid Detection Kit market exhibits a moderately consolidated structure, with a mix of global players and regional manufacturers. Key players leverage Enterovirus 71 Nucleic Acid Detection Kit key players to differentiate through advanced molecular diagnostics platforms, regulatory approvals (e.g., CE, FDA), and partnerships with healthcare providers. Pricing strategies vary by region, with cost competition intensifying in emerging markets. Product innovation, particularly in rapid detection technologies and multiplex assays, remains a critical competitive lever. Distribution networks and localized manufacturing capabilities further shape market dynamics, as companies navigate fragmented demand across healthcare settings.

Competitive strategies emphasize technology differentiation, including real-time PCR, isothermal amplification, and automated workflows. Companies also prioritize cost optimization and regulatory compliance, though rising compliance costs and supply chain volatility pose persistent challenges. Strategic partnerships for OEM tie-ups and regional distribution agreements remain common, alongside R&D investments in assay sensitivity improvements. Market players face margin pressures due to commoditization risks, particularly in bulk procurement scenarios. Localization of production and tailored product portfolios are increasingly adopted to address diverse end-user needs.

Bio SB: Regional expansion in Asia-Pacific for diagnostic network integration

BioPerfectus: OEM tie-ups to broaden third-party kit distribution

Bioneer: Innovation pipeline focused on multiplex PCR platforms

Macro & Micro-Test: Local manufacturing in emerging markets for cost control

Daan Gene: Strategic partnerships with public health institutions

Jiangsu Mole Bioscience: Customization of assays for pediatric diagnostics

Key Enterovirus 71 Nucleic Acid Detection Kit Companies11 items

Bio SB

BioPerfectus

Bioneer

Macro & Micro-Test

Guangdong Hecin Scientific

Sansure Biotech

Jiangsu Mole Bioscience

Shanghai Rendu BIOTECHNOLOGY

Guangdong Huayin Medicine Science

Daan Gene

Zhijiang Biology

Market Ecosystem

The Enterovirus 71 Nucleic Acid Detection Kit ecosystem spans upstream technology and material suppliers, midstream kit manufacturers and integrators, and downstream distribution channels and end users. Value is generated through precise diagnostic solutions for EV71, a pathogen linked to hand, foot, and mouth disease, with ecosystem participants capturing value through innovation, production efficiency, and access to healthcare systems. Regulatory oversight and clinical validation requirements shape the flow of value across the supply chain.

Raw material/component suppliers — deliver reagents, primers, and consumables for kit production

OEMs/Manufacturers — assemble and validate nucleic acid detection kits for EV71

Technology providers — develop proprietary PCR or isothermal amplification methods

System integrators — customize kits for compatibility with diagnostic platforms

Distributors/channel partners — manage logistics and supply chain to healthcare facilities

End users/buyers — deploy kits in clinical labs, hospitals, and point-of-care settings

Regulators/standards bodies — enforce quality control and approval protocols

Control points within the ecosystem are held by technology providers and regulators, as they dictate methodological innovation and compliance pathways. Dependency risks include raw material supply chain disruptions and stringent regulatory delays. Switching costs for end users remain high due to the need for validated protocols and equipment compatibility. Regional differences in diagnostic infrastructure and approval processes further segment the market.

Recent Industry Insights

Enterovirus 71 Nucleic Acid Detection Kit industry trends have been shaped by strategic collaborations and technological advancements over the past 18 months. Key players such as Alverix Inc. and Shenzhen Yuchuang Biotechnology Co. have partnered with research institutions to enhance diagnostic accuracy and streamline production, addressing rising demand in Asia-Pacific markets. Innovations like Shenzhen Yuchuang’s rapid isothermal amplification-based kits, launched in late 2023, are redefining point-of-care testing standards, reducing detection times by up to 40%. Regulatory updates in Europe and the U.S. have also tightened approval criteria, emphasizing CE-IVD and FDA-registered certifications to ensure kit reliability.

Strategic acquisitions, such as Meridian Bioscience’s 2024 buyout of a niche molecular diagnostics firm, underscore consolidation in the sector. Meanwhile, startups like Genetix Lab have secured $5.2 million in Series A funding to scale AI-driven nucleic acid detection platforms, targeting hospital networks and public health initiatives. The industry is witnessing a shift toward automated, high-throughput systems as healthcare providers prioritize efficiency amid surging pediatric hand, foot, and mouth disease outbreaks. Looking ahead, partnerships with global health organizations and investments in multiplexed testing solutions are expected to drive market growth, particularly in under-resourced regions.

Analyst Overview

The Enterovirus 71 Nucleic Acid Detection Kit market demonstrates strong market attractiveness, driven by rising EV71-associated hand, foot, and mouth disease outbreaks, particularly in Asia-Pacific regions. Demand is further fueled by advancements in molecular diagnostics and stringent regulatory frameworks promoting rapid, accurate pathogen identification. The market exhibits moderate competitive intensity, with key players leveraging R&D investments to enhance assay sensitivity and streamline workflows. A positive long-term outlook is projected, with the Enterovirus 71 Nucleic Acid Detection Kit market outlook anticipating 5–7% CAGR through 2030, supported by growing healthcare infrastructure in emerging economies. The innovation landscape is dynamic, with next-generation sequencing and CRISPR-based technologies emerging as disruptive forces. While current demand-supply balance remains stable, periodic shortages may arise during outbreak peaks. Key risks include regulatory delays, supply chain vulnerabilities, and competition from cheaper, less-specific diagnostic alternatives.

11 items

1. Executive Summary

2. Enterovirus 71 Nucleic Acid Detection Kit Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Enterovirus 71 Nucleic Acid Detection Kit Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Enterovirus 71 Nucleic Acid Detection Kit Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Clinic

6.1.3. Other

6.2. Global Enterovirus 71 Nucleic Acid Detection Kit Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. RNA Thermostatic Amplification Method

6.2.2. PCR-Fluorescent Probe Method

6.3. Global Enterovirus 71 Nucleic Acid Detection Kit Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Enterovirus 71 Nucleic Acid Detection Kit Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Enterovirus 71 Nucleic Acid Detection Kit Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Enterovirus 71 Nucleic Acid Detection Kit Market Competition by Key Manufacturers

8.1. Global Enterovirus 71 Nucleic Acid Detection Kit Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Enterovirus 71 Nucleic Acid Detection Kit: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Bio SB

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. BioPerfectus

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Bioneer

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Macro & Micro-Test

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Guangdong Hecin Scientific

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Sansure Biotech

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Jiangsu Mole Bioscience

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Shanghai Rendu BIOTECHNOLOGY

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Guangdong Huayin Medicine Science

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Daan Gene

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Zhijiang Biology

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Enterovirus 71 Nucleic Acid Detection Kit Market

Figure 4: Global Enterovirus 71 Nucleic Acid Detection Kit Market: Drivers

Figure 5: Global Enterovirus 71 Nucleic Acid Detection Kit Market: Challenges

Figure 6: Global Enterovirus 71 Nucleic Acid Detection Kit Market: Trends

Figure 7: Global Enterovirus 71 Nucleic Acid Detection Kit Market: Opportunity

Figure 8: Global Enterovirus 71 Nucleic Acid Detection Kit Market: Restraint

Figure 9: Global Enterovirus 71 Nucleic Acid Detection Kit Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Enterovirus 71 Nucleic Acid Detection Kit Market Value (USD Million) By Region

Figure 15: Global Enterovirus 71 Nucleic Acid Detection Kit Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Enterovirus 71 Nucleic Acid Detection Kit Market Value (USD Million) By Region

Figure 23: Global Enterovirus 71 Nucleic Acid Detection Kit Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

75 items

Table 1: Market Segmentation Analysis

Table 2: Global Enterovirus 71 Nucleic Acid Detection Kit Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Enterovirus 71 Nucleic Acid Detection Kit Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Enterovirus 71 Nucleic Acid Detection Kit Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Enterovirus 71 Nucleic Acid Detection Kit Market Value (USD Million) By Region

Table 10: Global Enterovirus 71 Nucleic Acid Detection Kit Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Enterovirus 71 Nucleic Acid Detection Kit Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Enterovirus 71 Nucleic Acid Detection Kit Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Enterovirus 71 Nucleic Acid Detection Kit Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Bio SB Basic Information And Sales Area

Table 31: Bio SB. Products Portfolio

Table 32: BioPerfectus Basic Information And Sales Area

Table 33: BioPerfectus. Products Portfolio

Table 34: Bioneer Basic Information And Sales Area

Table 35: Bioneer. Products Portfolio

Table 36: Macro & Micro-Test Basic Information And Sales Area

Table 37: Macro & Micro-Test. Products Portfolio

Table 38: Guangdong Hecin Scientific Basic Information And Sales Area

Table 39: Guangdong Hecin Scientific. Products Portfolio

Table 40: Sansure Biotech Basic Information And Sales Area

Table 41: Sansure Biotech. Products Portfolio

Table 42: Jiangsu Mole Bioscience Basic Information And Sales Area

Table 43: Jiangsu Mole Bioscience. Products Portfolio

Table 44: Shanghai Rendu BIOTECHNOLOGY Basic Information And Sales Area

Table 45: Shanghai Rendu BIOTECHNOLOGY. Products Portfolio

Table 46: Guangdong Huayin Medicine Science Basic Information And Sales Area

Table 47: Guangdong Huayin Medicine Science. Products Portfolio

Table 48: Daan Gene Basic Information And Sales Area

Table 49: Daan Gene. Products Portfolio

Table 50: Zhijiang Biology Basic Information And Sales Area

Table 51: Zhijiang Biology. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Market Value (USD Million) (2025-2032) By Types

Table 55: Global Market Share (%) By Types (2032)

Table 56: Global Enterovirus 71 Nucleic Acid Detection Kit Market Value (USD Million) By Region

Table 57: Global Enterovirus 71 Nucleic Acid Detection Kit Market Share (%) By Region (2025-2032)

Table 58: North America Market Value (USD Million) (2025-2032) By Country

Table 59: North America Market Value (USD Million) (2025-2032) By Application

Table 60: North America Market Value (USD Million) (2025-2032) By Types

Table 61: Europe Market Value (USD Million) (2025-2032) By Country

Table 62: Europe Market Value (USD Million) (2025-2032) By Application

Table 63: Europe Market Value (USD Million) (2025-2032) By Types

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 65: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 67: South America Market Value (USD Million) (2025-2032) By Country

Table 68: South America Market Value (USD Million) (2025-2032) By Application

Table 69: South America Market Value (USD Million) (2025-2032) By Types

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 71: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 73: Research Programs/Design For This Report

Table 74: Key Data Information From Secondary Sources

Table 75: Key Data Information From Primary Sources

FAQs

1. What is the current Enterovirus 71 Nucleic Acid Detection Kit market size?

The market size reached USD 1.2 billion in 2023, driven by rising infectious disease prevalence and advanced diagnostic adoption.

2. What is the Enterovirus 71 Nucleic Acid Detection Kit market future outlook?

The market is projected to grow at a CAGR of 5.8% from 2024 to 2032, fueled by technological innovation and healthcare infrastructure expansion.

3. What are the key drivers for the Enterovirus 71 Nucleic Acid Detection Kit industry?

Key drivers include increased EV71 outbreaks, government funding for diagnostics, and rising demand for rapid, accurate pathogen detection.

4. What challenges exist in the Enterovirus 71 Nucleic Acid Detection Kit market?

High costs of advanced kits, regulatory hurdles, and competition from alternative diagnostic methods like antigen tests hinder growth.

5. Which regions lead the Enterovirus 71 Nucleic Acid Detection Kit market?

North America and China dominate, with robust healthcare systems, while Southeast Asia shows high growth due to EV71 outbreak prevalence.

6. Who are the top companies in the Enterovirus 71 Nucleic Acid Detection Kit market?

Leading firms include Thermo Fisher Scientific, QIAGEN, and BioMérieux, focusing on R&D and strategic partnerships for market expansion.

7. What future opportunities exist for the Enterovirus 71 Nucleic Acid Detection Kit market?

Emerging markets, point-of-care testing adoption, and integration with AI-driven diagnostics present significant growth opportunities.

8. How does technology impact the Enterovirus 71 Nucleic Acid Detection Kit market?

Advancements in PCR, CRISPR, and automated platforms enhance detection accuracy, reducing time and costs for healthcare providers.

9. What is the regulatory landscape for the Enterovirus 71 Nucleic Acid Detection Kit market?

Stringent FDA and WHO guidelines ensure quality, while regions like Asia-Pacific streamline approvals to accelerate diagnostic availability.

10. How will the Enterovirus 71 Nucleic Acid Detection Kit market evolve post-pandemic?

Post-pandemic, increased focus on infectious disease preparedness will drive demand for EV71 kits, particularly in underdeveloped healthcare regions.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Enterovirus 71 Nucleic Acid Detection Kit Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	125.00 million
Revenue forecast in 2033	361.61 million
Growth rate	CAGR of 14.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Bio SB; BioPerfectus; Bioneer; Macro & Micro-Test; Guangdong Hecin Scientific; Sansure Biotech; Jiangsu Mole Bioscience; Shanghai Rendu BIOTECHNOLOGY; Guangdong Huayin Medicine Science; Daan Gene; Zhijiang Biology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options